FDA
-
-
-
-
-
-
-
TuHURA Biosciences and Kintara Therapeutics Announce Positive Results from Phase 1b Trial of IFx-2.0, a Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcin
-
-
-
-
-
-
-
Kintara Therapeutics to Participate in the Fifth Annual Glioblastoma Awareness Day in Washington, D.C.
-
-
-
-
-
-
-
Kintara Therapeutics (KTRA) Approved to Proceed with REM-001 Study
-
-
-
-
-
-
-
Kintara Therapeutics Announces Fiscal Year 2021 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Kintara Therapeutics (KTRA) Enrolls Final Patient in Phase 2 Trial of VAL-083 for Brain Tumors
-
-
-
-
-
-
-
Proactive news headlines including BetterLife Pharma, HempFusion Wellness, Pure Gold Mining, Mirasol Resources and OTC Markets Group
-
-
-
-
-
-
323,584 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

